JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$1.67B |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$1.66B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.14B |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$966M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$877M |
Top Sells
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.11B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 3 |
Microsoft
MSFT
|
+$933M |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$921M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$787M |
Sector Composition
| 1 | Technology | 15.74% |
| 2 | Healthcare | 11.55% |
| 3 | Financials | 11.4% |
| 4 | Consumer Discretionary | 9.54% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STXB
3401
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $281K | ﹤0.01% |
27,247
+10,094
| +59% | +$104K |
|
|
EIGI
3402
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $281K | ﹤0.01% |
145,773
+122,163
| +517% | +$235K |
|
3403
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| $280K | ﹤0.01% |
5,115
+144
| +3% | +$7.88K |
|
3404
PennantPark Floating Rate Capital
PFLT
$1.01B
| $279K | ﹤0.01% |
57,361
+12,050
| +27% | +$58.6K |
|
|
NPKI
3405
NPK International Inc.
NPKI
$889M
| $279K | ﹤0.01% |
310,486
+208,505
| +204% | +$187K |
|
|
DCPH
3406
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $279K | ﹤0.01% |
6,789
-80,401
| -92% | -$3.3M |
|
3407
Transmedics
TMDX
$3.91B
| $278K | ﹤0.01% |
23,051
+13,988
| +154% | +$169K |
|
|
IBTX
3408
DELISTED
Independent Bank Group, Inc.
IBTX
| $278K | ﹤0.01% |
11,758
-47,880
| -80% | -$1.13M |
|
3409
ANI Pharmaceuticals
ANIP
$2.12B
| $277K | ﹤0.01% |
6,801
-276
| -4% | -$11.2K |
|
3410
South Plains Financial
SPFI
$646M
| $276K | ﹤0.01% |
17,832
+5,284
| +42% | +$81.8K |
|
|
FPI
3411
Farmland Partners
FPI
$481M
| $273K | ﹤0.01% |
44,960
-4,058
| -8% | -$24.6K |
|
|
EFC
3412
Ellington Financial
EFC
$1.34B
| $271K | ﹤0.01% |
47,423
-78,984
| -62% | -$451K |
|
3413
Norwood Financial Corp
NWFL
$245M
| $271K | ﹤0.01% |
10,173
+2,286
| +29% | +$60.9K |
|
3414
BCB Bancorp
BCBP
$148M
| $270K | ﹤0.01% |
25,405
+10,506
| +71% | +$112K |
|
|
ESXB
3415
DELISTED
Community Bankers Trust Corporation
ESXB
| $270K | ﹤0.01% |
55,820
+17,233
| +45% | +$83.4K |
|
3416
Emerald Holding
EEX
$980M
| $269K | ﹤0.01% |
103,897
-99,139
| -49% | -$257K |
|
|
SUP
3417
DELISTED
Superior Industries International
SUP
| $269K | ﹤0.01% |
224,016
-246,816
| -52% | -$296K |
|
|
PWOD
3418
DELISTED
Penns Woods Bancorp
PWOD
| $268K | ﹤0.01% |
11,072
+2,166
| +24% | +$52.4K |
|
3419
AstroNova
ALOT
$76.1M
| $267K | ﹤0.01% |
34,370
-961
| -3% | -$7.47K |
|
3420
Geospace Technologies
GEOS
$209M
| $267K | ﹤0.01% |
41,695
+35,820
| +610% | +$229K |
|
|
HEES
3421
DELISTED
H&E Equipment Services
HEES
| $265K | ﹤0.01% |
18,009
-1,177,100
| -98% | -$17.3M |
|
3422
LifeVantage
LFVN
$141M
| $265K | ﹤0.01% |
25,775
+21,265
| +472% | +$219K |
|
3423
Riverview Bancorp
RVSB
$102M
| $265K | ﹤0.01% |
53,037
-32,296
| -38% | -$161K |
|
|
GEN
3424
DELISTED
Genesis Healthcare, Inc.
GEN
| $265K | ﹤0.01% |
313,899
-73,922
| -19% | -$62.4K |
|
|
ADAP
3425
Adaptimmune Therapeutics
ADAP
$14.8M
| $264K | ﹤0.01% |
96,737
+20,531
| +27% | +$56K |
|